Prasinomed

About This Project

Skin is the largest organ in the human body, providing a protective physical barrier for muscles, bones ligaments and internal organs. It is constantly exposed to physical, chemical and biological factors that cause damage by creating wounds. However, the development of new and effective interventions in the wound-care market still remains an area of intense research, as more than 100M people annually suffer from this problem. Modern wound-care products are not providing the necessary level of hydration and due to un-natural substances in the formulation in some cases cause allergic reactions.

 

Prasinomed is a novel cream for the wound-care market. The cream is based on high quality non-genetically modified, ecologically favourable biological production. Due to formulation from naturally occurring microalgae-prasinococus capsulatus, Prasinomed offers a sustainable, antiallergenic and hydrating cream.

Topic
PHC-12 - Clinical research for the validation of biomarkers and/or diagnostic medical devices
Year

2018

Cutoff

May

Beneficiaries

Coordinator

PrasinoTech Ltd.

Country

United Kingdom

Website

Link